AlphanoxLtd Past Earnings Performance

Past criteria checks 0/6

AlphanoxLtd's earnings have been declining at an average annual rate of -3.6%, while the Medical Equipment industry saw earnings growing at 16.5% annually. Revenues have been growing at an average rate of 4.7% per year.

Key information

-3.6%

Earnings growth rate

1.4%

EPS growth rate

Medical Equipment Industry Growth22.7%
Revenue growth rate4.7%
Return on equity-86.0%
Net Margin-69.2%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Is Solco Biomedical (KOSDAQ:043100) Using Debt In A Risky Way?

Jun 27
Is Solco Biomedical (KOSDAQ:043100) Using Debt In A Risky Way?

Solco Biomedical Co., Ltd.'s (KOSDAQ:043100) 27% Dip In Price Shows Sentiment Is Matching Revenues

Jun 27
Solco Biomedical Co., Ltd.'s (KOSDAQ:043100) 27% Dip In Price Shows Sentiment Is Matching Revenues

Solco Biomedical Co., Ltd.'s (KOSDAQ:043100) Share Price Boosted 40% But Its Business Prospects Need A Lift Too

Feb 27
Solco Biomedical Co., Ltd.'s (KOSDAQ:043100) Share Price Boosted 40% But Its Business Prospects Need A Lift Too

Revenue & Expenses Breakdown

How AlphanoxLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A043100 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2427,314-18,89616,0832,325
31 Mar 2427,721-18,32616,1732,460
31 Dec 2326,878-19,96616,2922,263
30 Sep 2325,504-11,73313,9372,285
30 Jun 2324,869-11,04912,1122,356
31 Mar 2323,869-10,51911,5442,110
31 Dec 2223,396-9,52810,6171,923
30 Sep 2223,974-6,29911,8261,652
30 Jun 2223,501-5,83612,5781,535
31 Mar 2223,769-4,98311,9501,350
31 Dec 2123,951-4,07511,4981,408
30 Sep 2123,798-1757,9951,214
30 Jun 2124,316-5307,4031,155
31 Mar 2123,2091,1885,4441,188
31 Dec 2022,8541,6475,4421,018
30 Sep 2021,555-11,2569,0021,008
30 Jun 2021,158-11,5879,274833
31 Mar 2021,756-16,84114,504824
31 Dec 1921,442-18,76415,501955
30 Sep 1921,333-16,92017,5511,081
30 Jun 1922,344-17,83718,906888
31 Mar 1922,222-15,64116,360980
31 Dec 1822,541-15,35015,9611,187
30 Sep 1823,551-6,44511,5041,037
30 Jun 1823,007-7,23111,3051,037
31 Mar 1823,822-7,61310,9641,336
31 Dec 1723,211-8,52810,5101,780
30 Sep 1722,857-9,59311,3252,305
30 Jun 1722,554-9,05811,4352,305
31 Mar 1722,204-8,93511,2692,207
31 Dec 1623,722-7,98310,8752,083
30 Sep 1624,189-8,43211,9701,722
30 Jun 1624,174-8,40311,5841,722
31 Mar 1622,986-7,83811,8301,477
31 Dec 1522,432-7,00611,0401,004
30 Sep 1525,154-1,0947,3091,116
30 Jun 1525,063-2,2277,6641,116
31 Mar 1527,940-1,78212,521871
31 Dec 1430,141-2,17513,488871
30 Sep 1431,154-7,42615,703734
30 Jun 1433,051-5,58816,262734
31 Mar 1434,506-5,47411,354820
31 Dec 1335,499-5,01611,721879
30 Sep 1337,017-5,12413,036711

Quality Earnings: A043100 is currently unprofitable.

Growing Profit Margin: A043100 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A043100 is unprofitable, and losses have increased over the past 5 years at a rate of 3.6% per year.

Accelerating Growth: Unable to compare A043100's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A043100 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.6%).


Return on Equity

High ROE: A043100 has a negative Return on Equity (-86.01%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies